Early Onset of SARS-COV-2 Antibodies after First Dose of BNT162b2: Correlation with Age, Gender and BMI.
Raul PelliniAldo VenutiFulvia PimpinelliElva AbrilGiovanni BlandinoFlaminia CampoLaura ContiArmando De VirgilioFederico De MarcoEnea Gino Di DomenicoOrnella Di BellaSimona Di MartinoFabrizio EnsoliDiana GiannarelliChiara MandojValentina MancioccoPaolo MarchesiFrancesco MazzolaSilvia MorettoGerardo PetruzziFabrizio PetroneBarbara PichiMartina PontoneJacopo ZocchiAntonello VidiriBranka VujovicGiulia PiaggioAldo MorroneGennaro CilibertoPublished in: Vaccines (2021)
Our study demonstrates that a single dose of BNT162b2 activates the immune response, and being young and normal-weight correlate positively with this response. Larger specifically designed clinical trials are needed to validate these results.